LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
about
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens.Lysergic acid diethylamide: a drug of 'use'?d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Return of the lysergamides. Part II: Analytical and behavioural characterization of N(6) -allyl-6-norlysergic acid diethylamide (AL-LAD) and (2'S,4'S)-lysergic acid 2,4-dimethylazetidide (LSZ)PsychedelicsD-amphetamine and antipsychotic drug effects on latent inhibition in mice lacking dopamine D2 receptors.LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor.Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).Psilocybin-induced stimulus control in the rat.Genie in a blotter: A comparative study of LSD and LSD analogues' effects and user profile.Therapeutic Applications of Classic Hallucinogens.Return of the lysergamides. Part III: Analytical characterization of N6 -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).Evaluation of common gene expression patterns in the rat nervous system.Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
P2860
Q24620764-4B6EDAB3-B16D-4F84-B698-7A090D16F553Q26746133-94AB7265-7C9B-4771-AA8A-ED339C42284CQ28067851-EF4D2457-1C9D-4F46-AA28-7913CBFC49B2Q28276150-EFD0B2AE-EC16-4E79-8C45-AF3DEEF5D4F9Q30359998-0B31604B-6C26-4564-90E8-51D8A76F16CCQ30453020-930B1DAD-0B5B-4BD3-8FF3-937A0E58761CQ30484494-3E98E627-84C3-469A-8BDD-55992E1A551DQ34087847-508C5726-03C2-4B00-80AB-9134DC409335Q34497649-15FC8F62-A1AA-41DE-A4C9-E5CDBED72CA2Q35737157-505723BA-D867-4954-A6A2-93339DE856FAQ36023615-EFDBF241-BBD1-4EB0-BB19-A7F141D41472Q38682464-06EE6089-CAD4-4556-A71A-61D08318CE94Q38781678-9CEA196C-5BA9-46D9-A061-EFEC2B653857Q38877013-84D6C017-F679-4D2A-B2FA-FFBC27B01451Q44695997-4D57093C-B27C-42D6-A916-91D0A024769CQ46573497-0AE6F54D-9377-4145-A03D-1D43548BD57F
P2860
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@ast
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@en
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@nl
type
label
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@ast
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@en
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@nl
prefLabel
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@ast
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@en
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@nl
P2093
P356
P1433
P1476
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptors
@en
P2093
P2888
P356
10.1007/BF02245940
P407
P577
1995-04-01T00:00:00Z
P6179
1024852357